Latest News and Press Releases

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Willis Towers Watson plc (“Willis Towers Watson” or the “Company”) (NASDAQ: WTW). Such...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Entrada Therapeutics, Inc. (“Entrada” or the “Company”) (NASDAQ: TRDA).  Such investors are...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ryan Specialty Holdings, Inc. (“Ryan” or the “Company”) (NYSE: RYAN). Such investors are...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cogent Communications Holdings, Inc. (“Cogent” or the “Company”) (NASDAQ: CCOI). Such...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Norwegian Cruise Line Holdings Ltd. (“Norwegian” or the “Company”) (NYSE: NCLH).  Such...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amplitude, Inc. (“Amplitude” or the “Company”) (NASDAQ: AMPL).  Such investors are advised...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp. (“GeneDx” or the “Company”) (NASDAQ: WGS). Such investors are advised...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Clorox Company (“Clorox” or the “Company”) (NYSE: CLX).  Such investors are advised to...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fiverr International Ltd. (“Fiverr” or the “Company”) (NYSE: FVRR). Such investors are...

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are...